These data not only demonstrate the potentially novel immunoregulatory function of CDCP1 beyond its established role in tumor biology, but also suggest that CDCP1 may be a new therapeutic target in human autoimmune uveitis. This evidence concerns the gene CDCP1 and autoimmune uveitis.